<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Wyndham Hotel Corporation
- - --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
- - --------------------------------------------------------------------------------
(Title of Class of Securities)
983100 10 8
------------------
(CUSIP Number)
Wynopt Investment Partnership Level II, L.P.
4200 Texas Commerce Tower West
2200 Ross Ave.
Dallas, Texas 75201
Attention: Robert A. Whitman
(214) 220-4900
- - --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
With a copy to:
Robert A. Profusek, Esq.
Jones, Day, Reavis & Pogue
599 Lexington Avenue
New York, New York
(212) 326-3939
May 24, 1996
-------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this statement [x].
Page 1
Index to Exhibits on Page 22
<PAGE> 2
SCHEDULE 13D
CUSIP NO. 983100 10 8 PAGE 2
- - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Wynopt Investment Partnership Level II, L.P.
- - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
AF, OO (See Item 3.)
- - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- - --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES -------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
2,276,055
OWNED BY
------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON ------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
2,276,055
- - -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,276,055
- - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/X/
- - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.37%
- - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- - --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 3
SCHEDULE 13D
CUSIP NO. 983100 10 8 PAGE 3
- - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Hampstead Genpar, L.P.
- - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (See Item 3.)
- - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- - --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES -------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
2,276,055
OWNED BY
------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON ------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
2,276,055
- - -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,276,055
- - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/X/
- - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.37%
- - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- - --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 4
SCHEDULE 13D
CUSIP NO. 983100 10 8 PAGE 4
- - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HH Genpar Partners
- - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (See Item 3.)
- - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- - --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES -------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
2,276,055
OWNED BY
------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON ------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
2,276,055
- - -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,276,055
- - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/X/
- - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.37%
- - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- - --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 5
SCHEDULE 13D
CUSIP NO. 983100 10 8 PAGE 5
- - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Hampstead Associates, Inc.
- - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (See Item 3.)
- - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
- - --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES -------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
2,276,055
OWNED BY
------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON ------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
2,276,055
- - -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,276,055
- - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/X/
- - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.37%
- - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- - --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 6
SCHEDULE 13D
CUSIP NO. 983100 10 8 PAGE 6
- - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
RAW Genpar, Inc.
- - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (See Item 3.)
- - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
- - --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES -------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
2,276,055
OWNED BY
------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON ------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
2,276,055
- - -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,276,055
- - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/X/
- - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.37%
- - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- - --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 7
SCHEDULE 13D
CUSIP NO. 983100 10 8 PAGE 7
- - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
InMed, Inc. (d/b/a/InCap, Inc.)
- - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (See Item 3.)
- - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
- - --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES -------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
2,276,055
OWNED BY
------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON ------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
2,276,055
- - -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,276,055
- - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/X/
- - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.37%
- - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- - --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 8
SCHEDULE 13D
CUSIP NO. 983100 10 8 PAGE 8
- - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Donald J. McNamara
- - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (See Item 3.)
- - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- - --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES -------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
2,276,055
OWNED BY
------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON ------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
2,276,055
- - -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,276,055
- - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/X/
- - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.37%
- - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- - --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 9
SCHEDULE 13D
CUSIP NO. 983100 10 8 PAGE 9
- - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert A. Whitman
- - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (See Item 3.)
- - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- - --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES -------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
2,276,055
OWNED BY
------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON ------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
2,276,055
- - -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,276,055
- - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/X/
- - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.37%
- - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- - --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 10
SCHEDULE 13D
CUSIP NO. 983100 10 8 PAGE 10
- - --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Daniel A. Decker
- - --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /X/
(b) / /
- - --------------------------------------------------------------------------------
3 SEC USE ONLY
- - --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (See Item 3.)
- - --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- - --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- - --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES -------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
2,276,055
OWNED BY
------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING -0-
PERSON ------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
2,276,055
- - -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,276,055
- - --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/X/
- - --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.37%
- - --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- - --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 11
Item 1. Security and Issuer.
This statement relates to shares of the common stock, par value $.01
per share (the "Common Stock"), of Wyndham Hotel Corporation, a Delaware
corporation (the "Company"). The principal executive offices of the Company
are located at 2001 Bryan Street, Suite 2300, Dallas, Texas 75201, and its
telephone number at such address is (214) 863-1000.
Item 2. Identity and Background.
(a)-(c), (f). This statement is filed by (i) Wynopt Investment
Partnership Level II, L.P., a Delaware limited partnership ("Wynopt"); (ii)
Hampstead Genpar, L.P., a Delaware limited partnership ("Hampstead Genpar");
(iii) HH Genpar Partners, a Texas general partnership ("HH Genpar"); (iv)
Hampstead Associates, Inc., a Texas corporation ("Associates"); (v) RAW Genpar,
Inc., a Texas corporation ("RAW Genpar"); (vi) InMed, Inc. (d/b/a InCap, Inc.),
a Texas corporation ("InMed"); (vii) Donald J. McNamara; (viii) Robert A.
Whitman; and (ix) Daniel A. Decker. Messrs. McNamara, Whitman and Decker are
United States citizens. Messrs. Whitman and Decker are members of the Board of
Directors of the Company. Holdings, Hampstead Genpar, HH Genpar, Associates,
RAW Genpar, InMed and Messrs. McNamara, Whitman and Decker are referred to
herein collectively as the "Reporting Persons."
The principal business of Wynopt is to invest in the Company.
Hampstead Genpar is, and its principal business is to act as, the sole general
partner of Wynopt. HH Genpar is, and its principal business is to act as, the
managing general partner of Hampstead Genpar (and various other partnerships).
Associates is, and its principal business is to act as, the managing general
partner of HH Genpar. RAW Genpar and InMed are the only other general partners
of HH Genpar. The principal business of each of RAW Genpar and InMed is to
invest in HH Genpar. The address of the principal executive office of
Hampstead Genpar, HH Genpar Associates, RAW Genpar and InMed is 4200 Texas
Commerce Tower West, 2200 Ross Avenue, Dallas, Texas 75201.
The principal occupation of each of Donald J. McNamara, Robert A.
Whitman and Daniel A. Decker is to be employed by The Hampstead Group, L.L.C.
("Hampstead"). Mr. McNamara is the Chairman and Co-Chief Executive Officer of
Hampstead, Mr. Whitman is the President and Co-Chief Executive Officer of
Hampstead, and Mr. Decker is the Executive Vice President and General Counsel
of Hampstead. The principal business of Hampstead is to provide real estate
investment and management services. The business address of Hampstead and of
each such individual is 4200 Texas Commerce Tower West, 2200 Ross Avenue,
Dallas, Texas 75201.
Page 11
<PAGE> 12
(d)-(e). None of the Reporting Persons has during the past
five years (i) been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors) or (ii) been a party to a civil proceeding
of a judicial or administrative body of competent jurisdiction that resulted in
a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state securities
laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
Wynopt acquired 2,276,055 shares of Common Stock on May 24, 1996.
Such shares were acquired pursuant to an Exchange Agreement, dated as of March
10, 1996, among the Company, Wyndham Hotel Company, Ltd., Wynopt, Wynopt
Investment Partnership, L.P. and Hampstead and joined in by Bedrock Hotel
Partners, L.L.C. (the "Exchange Agreement") in exchange for the contribution to
the Company of (i) cash in the amount of $10.0 million, and (ii) the transfer
of certain equity interests in the Company acquired by Wynopt pursuant to an
Option Agreement dated as of May 2, 1994. The funds required by Wynopt for the
transaction were obtained directly from the investors in Wynopt. The Exchange
Agreement is incorporated herein by reference to Exhibit 10.12 to the Company's
Registration Statement on Form S-1 (Registration No. 333-2214).
Item 4. Purpose of Transaction.
Wynopt acquired the shares of Common Stock held by it pursuant to the
Exchange Agreement for investment purposes. The Reporting Persons may purchase
additional shares of Common Stock either in the open market or in private
transactions, depending on their evaluations of the Company's business,
prospects and financial condition, the market for the Common Stock, economic
conditions, money and stock market conditions and other future developments.
Depending upon similar factors, and subject to the limitation described below,
the Reporting Persons may dispose of such shares of Common Stock.
Stockholders' Agreement. On May 24, 1996, Wynopt entered into a
stockholders' Agreement (the "Stockholders' Agreement") with the Company,
various affiliates of Hampstead (the "Hampstead Stockholders"), certain other
senior executive officers of the Company, Wyndham Employees Ltd. ("WEL") and
certain other parties (collectively, the "Crow/Wyndham Stockholders"), which
imposes certain restrictions on the transfer of Common Stock held by such
stockholders (the "Stockholders") and entitles the Stockholders to certain
rights regarding corporate governance.
Pursuant to the Stockholders' Agreement, each of the Stockholders
agreed not to sell, transfer, pledge or otherwise dispose of ("Transfer") its
Common Stock otherwise than as
Page 12
<PAGE> 13
permitted by the provisions of the Stockholders' Agreement. The Stockholders'
Agreement permits the following transfers: (i) open-market sales not exceeding
the volume limitations imposed by Rule 144 under the Securities Act of 1933, as
amended, (ii) sales in the Company's initial public offering, and (iii)
Transfers of Common Stock by WEL to the direct or indirect owners of equity
interests in WEL. The Stockholders' Agreement also provides that any
Stockholders may Transfer any Common Stock, provided that the transferee agreed
to be bound by the Stockholders' Agreement, (a) to any wholly owned affiliate
of the transferring Stockholder, (b) to certain transferring Stockholder family
members, trusts or, if the transferring Stockholder is a corporation,
partnership or other entity, its equity owners, (c) to certain members of the
Crow family or their lineal descendants (the "Crow Interests"), (d) to the
Company or to any then-existing Crow/Wyndham Stockholder or to any full time
senior executive officers of the Company, (e) as a pledge to secure
indebtedness, provided that the pledgee agreed to offer a right of purchase, in
the event of any foreclosures of the pledge, to the other Stockholders in
accordance with the Stockholders' Agreement, and (f) to the owners of equity
interests in a Stockholder upon a partial or complete liquidation or
dissolution of such Stockholder.
The Stockholders' Agreement further provides that except with respect
to a permitted Transfer described above the proposed transfer by a Stockholder
to a third party of Common Stock will be subject to a first right of purchase
in favor of the Stockholders in the other Stockholder Group (as defined below)
at the price and on the other terms of the proposed third-party sale. The
Company has a prior right to purchase Common Stock subject to a proposed
Transfer if the offered Common Stock represents all of the Common Stock held by
the Crow Interests, but only to the extent the purchase by the Hampstead
Stockholders of the Common Stock would cause the Hampstead Stockholders to own
more than 40% of the outstanding Common Stock. A similar first right of
purchase requirement applies in the event of third-party sales in connection
with a shelf registration or an underwritten public offering in which
Stockholders propose to sell Common Stock.
Under the Stockholders' Agreement, the Hampstead Stockholders and the
Crow/Wyndham Stockholders (each a "Stockholder Group") are each entitled to
nominate a proportionate number of shares of Common Stock held by each
Stockholder Group and to be allocated as proportionately as practicable between
Independent Directors and other directors. Each Stockholder Group is also
entitled to nominate directors to serve on each of the Board's Committees on a
similar proportionate basis. Subject to certain conditions set forth in the
Stockholders' Agreement, each Stockholder Group agreed to use its best efforts
to elect the director nominated in accordance with the Stockholders' Agreement
and to remove directors under certain circumstances. The Stockholders'
Agreement further provides that as long as the Crow Interests own at least 30%
of
Page 13
<PAGE> 14
the outstanding Common Stock (excluding any shares acquired from a third party
after the date of the Stockholders' Agreement), the Chairman of the Board of
the Company shall be a person designated by the Crow Interests. In the event
the Hampstead Stockholders own at least 30% of the outstanding Common Stock
(excluding any shares acquired from a third party after the date of the
Stockholders' Agreement) and the Crow Interests no longer own at least such
percentage, the Chairman of the Board of the Company shall be a person
designated by the Hampstead Stockholders.
The Stockholders' Agreement terminates upon the earliest to occur of
(a) the sixth anniversary of the date of the Stockholders' Agreement, (b) the
Hampstead Stockholders and the Crow/Wyndham Stockholders collectively owning
less than 37.5% of the outstanding Common Stock of the Company, (c) the
termination of management contracts under the Investment Program below a
specified level, (d) certain changes in control of the Hampstead Stockholders,
(e) the Hampstead Stockholders owning less than 50% of the number of shares of
Common Stock held by them immediately following the Company's initial public
offering and (f) any distribution of Common Stock by the Hampstead Stockholders
to direct or indirect owners of equity interests in the Hampstead Stockholders
that result in such Common Stock being held by anyone other than a Hampstead
principal or an entity controlled by such a principal.
The foregoing description of the Stockholders' Agreement is qualified
in its entirety by reference to the form of Stockholders Agreement incorporated
herein by reference to Exhibit 10.13 to the Company's Registration Statement on
Form S-1 (Registration No. 333-2214).
Registration Rights Agreement. On May 24, 1996, the Company entered
into a registration rights agreement with Hampstead, CF Securities, L.P.,
Harlan R. Crow, Susan T. Groenteman, James D. Carreker, Wynopt and certain
other parties (the "Registration Rights Agreement") pursuant to which the
Company agreed, subject to certain limitations and under certain circumstances,
to register for sale any shares of Common Stock (and other securities of the
Company that are exercisable to purchase, convertible into or exchangeable for
shares of capital stock of the Company) that are held by the parties thereto
(collectively, the "Registrable Securities"). All of the shares of Common
Stock beneficially owned by the Reporting Persons will be Registrable
Securities. The Registration Rights Agreement provides that any holder of
Registrable Securities may require the Company upon written notice to register
for sale such Registrable Securities (a "Demand Registration"), provided that
the total amount of Registrable Securities to be included in the Demand
Registration has a market value of at least $20 million and provided that
notice is not given prior to six months after the effective date of the
previous Demand Registration. If Registrable Securities are going to be
registered by the Company pursuant to a Demand Registration, the Company must
provide written notice to the
Page 14
<PAGE> 15
other holders of Registrable Securities and permit them to include any or all
Registrable Securities that they hold in the Demand Registration, provided that
the amount of Registrable Securities requested to be registered may be limited
by the underwriters in an underwritten offering based on such underwriters'
determination that inclusion of the total amount of Registrable Securities
requested for registration would materially and adversely affect the success of
the offering. Upon notice of a Demand Registration, the Company is required to
file a Registration Statement within 60 days of the date on which notice is
given, although the Company may postpone the filing for up to 90 days under
certain circumstances. Subject to the conditions stated or referred to above,
the holders of Registrable Securities may request an unlimited number of Demand
Registrations. Hampstead and certain other parties to the Registration Rights
Agreement have agreed not to exercise any Demand Registration rights for a
period of six months from the date of execution of the Registration Rights
Agreement. WEL (as defined in the Registration Rights Agreement) has a one
time right to require the Company to register the Registrable Securities that
it holds in connection with the distribution of the Registrable Securities to
the WEL participants (the "WEL Registration"). Other holders of Registrable
Securities may not join the WEL Registration. A WEL Registration is not a
Demand Registration and it is not subject to the restrictions on a Demand
Registration, including the $20 million market value requirement.
The Registration Rights Agreement also provides that, subject to
certain exceptions, in the event the Company proposes to file a registration
statement with respect to an offering of any class of equity securities, other
than a WEL Registration and certain other types of registrations, the Company
will offer the holders of Registrable Securities the opportunity to register
the number of Registrable Securities they request to include (the "Piggyback
Registration"), provided that the amount of Registrable Securities requested to
be registered may be limited by the underwriters in an underwritten offering
based on such underwriters' determination that inclusion of the total amount of
Registrable Securities requested for registration would materially and
adversely affect the success of the offering.
The Company is generally required to pay all of the expenses of Demand
Registrations, the WEL Registration and Piggyback Registration, other than
underwriting discounts and commissions. In the event of a Demand Registration
within one year of the date of the Registration Rights Agreement, the holders
of the Registrable Securities being registered must pay up to $250,000
($125,000 in the case of a shelf registration) of such expenses.
The foregoing description of the Registration Rights Agreement is
qualified in its entirety by reference to the form of Registration Rights
Agreement incorporated herein by reference
Page 15
<PAGE> 16
to Exhibit 10.14 to the Company's Registration Statement on Form S-1
(Registration No. 333-2214).
Item 5. Interest in Securities of the Issuer.
(a) Each of the Reporting Persons beneficially owns 2,276,055
shares of Common Stock. Wynopt owns such shares directly and each of the other
Reporting Persons beneficially owns such shares indirectly through the
relationships described in Item 2 above. Messrs. McNamara, Whitman and Decker
disclaim beneficial ownership of all Common Stock held by Wynopt.
(b) Each of the Reporting Persons has shared power to vote and
dispose of 2,276,055 shares of Common Stock. Messrs. McNamara, Whitman and
Decker disclaim beneficial ownership of all Common Stock held by Wynopt.
(c) Not applicable.
(d) Not applicable.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relations with Respect to
Securities of the Issuer.
Stockholders Agreement. See Item 4 above.
Registration Rights Agreement. See Item 4 above.
An institutional investor has the right to obtain an interest in the
shares of Common Stock to which this statement relates through investment in an
affiliate of the Reporting Persons. If such institutional investor makes such
investment, a portion of such shares will be transferred to such affiliate.
However, in these circumstances, the Reporting Persons will continue to be the
beneficial owners of all such shares, and the institutional investor will not
have beneficial ownership thereof within the meaning of Rule 13d-3 under the
Securities and Exchange Act of 1934, as amended.
Item 7. Material to be Filed as Exhibits.
Exhibit 1 - Exchange Agreement, dated as of March 10, 1996
(incorporated herein by reference to Exhibit 10.12 to the Company's
Registration Statement on Form S-1 (Registration No. 333-2214)).
Exhibit 2 - Stockholders Agreement, dated as of May 24, 1996
(incorporated herein by reference to Exhibit 10.13 to the Company's
Registration Statement on Form S-1 (Registration No. 333-2214)).
Page 16
<PAGE> 17
Exhibit 3 - Registration Rights Agreement, dated as of May 24, 1996
(incorporated herein by reference to Exhibit 10.14 to the Company's
Registration Statement on Form S-1 (Registration No. 333-2214)).
Exhibit 99 - Agreement Among Filing Parties (Filed herewith).
Page 17
<PAGE> 18
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be filed
collectively on behalf of it and each of Hampstead Genpar, L.P., HH Genpar
Partners, Hampstead Associates, Inc., RAW Genpar, Inc., InMed, Inc., Donald J.
McNamara, Robert A. Whitman and Daniel A. Decker.
Dated: June 3, 1996 WYNOPT INVESTMENT PARTNERSHIP
LEVEL II, L.P.
By: Hampstead Genpar, L.P.
Its General Partner
By: HH Genpar Partners
Its General Partner
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ Daniel A. Decker
-----------------------------
Daniel A. Decker
Executive Vice President
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of Wynopt Investment Partnership Level II, L.P., HH
Genpar Partners, Hampstead Associates, Inc., RAW Genpar, Inc., InMed, Inc.,
Donald J. McNamara, Robert A. Whitman and Daniel A. Decker.
Dated: June 3, 1996 HAMPSTEAD GENPAR, L.P.
By: HH Genpar Partners
Its General Partner
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ Daniel A. Decker
---------------------------
Daniel A. Decker
Executive Vice President
Page 18
<PAGE> 19
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of Wynopt Investment Partnership Level II, L.P.,
Hampstead Genpar, L.P., Hampstead Associates, Inc., RAW Genpar, Inc., InMed,
Inc., Donald J. McNamara, Robert A. Whitman and Daniel A. Decker.
Dated: June 3, 1996 HH GENPAR PARTNERS
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ Daniel A. Decker
-------------------------
Daniel A. Decker
Executive Vice President
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of Wynopt Investment Partnership Level II, L.P.,
Hampstead Genpar, L.P., HH Genpar Partners, RAW Genpar, Inc., InMed, Inc.,
Donald J. McNamara, Robert A. Whitman and Daniel A. Decker.
Dated: June 3, 1996 HAMPSTEAD ASSOCIATES, INC.
By: /s/ Daniel A. Decker
-------------------------
Daniel A. Decker
Executive Vice President
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of Wynopt Investment Partnership Level II, L.P.,
Hampstead Genpar, L.P., HH Genpar Partners, Hampstead Associates, Inc., InMed,
Inc., Donald J. McNamara, Robert A. Whitman and Daniel A. Decker.
Dated: June 3, 1996 RAW GENPAR, INC.
By: /s/ Robert A. Whitman
------------------------
Robert A. Whitman
President
Page 19
<PAGE> 20
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of Wynopt Investment Partnership Level II, L.P.,
Hampstead Genpar, L.P., HH Genpar Partners, Hampstead Associates, Inc., RAW
Genpar, Inc., Donald J. McNamara, Robert A. Whitman and Daniel A. Decker.
<TABLE>
<S> <C> <C> <C> <C>
Dated: June 3, 1996 INMED, INC.
By: /s/ Daniel A. Decker
----------------------
Daniel A. Decker
President
</TABLE>
After reasonable inquiry and to the best of his knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of him and each of Wynopt Investment Partnership Level II, L.P.,
Hampstead Genpar, L.P., HH Genpar Partners, Hampstead Associates, Inc., RAW
Genpar, Inc., InMed, Inc., Robert A. Whitman and Daniel A. Decker.
Dated: June 3, 1996 /s/ Donald J. McNamara
----------------------------
Donald J. McNamara
After reasonable inquiry and to the best of his knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of him and each of Wynopt Investment Partnership Level II, L.P.,
Hampstead Genpar, L.P., HH Genpar Partners, Hampstead Associates, Inc., RAW
Genpar, Inc., InMed, Inc., Donald J. McNamara and Daniel A. Decker.
Dated: June 3, 1996 /s/ Robert A. Whitman
----------------------------
Robert A. Whitman
Page 20
<PAGE> 21
After reasonable inquiry and to the best of his knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of him and each of Wynopt Investment Partnership Level II, L.P.,
Hampstead Genpar, L.P., HH Genpar Partners, Hampstead Associates, Inc., RAW
Genpar, Inc., InMed, Inc., Donald J. McNamara and Robert A. Whitman.
Dated: June 3, 1996 /s/ Daniel A. Decker
Daniel A. Decker
Page 21
<PAGE> 22
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
EXHIBIT DESCRIPTION PAGE
------- ----------- ----
<S> <C>
1 Exchange Agreement, dated as of March 10, 1996 (incorporated herein by
reference to Exhibit 10.12 to Wyndham Hotel Corporation's Registration
Statement on Form S-1 (Registration No. 333-2214) (the "Registration
Statement")).
2 Stockholders Agreement, dated as of May 24, 1996 (incorporated herein
by reference to Exhibit 10.13 to the Registration Statement).
3 Registration Rights Agreement, dated as of May 24, 1996 (incorporated
herein by reference to Exhibit 10.14 to the Registration Statement).
99 Agreement Among Filing Parties (filed herewith).
</TABLE>
Page 22
<PAGE> 1
AGREEMENT AMONG FILING PARTIES
THIS AGREEMENT is made and entered into on June 3, 1996, by and among
Wynopt Investment Partnership Level II, L.P., a Delaware limited partnership,
Hampstead Genpar, L.P., a Delaware limited partnership, H H Genpar Partners, a
Delaware limited partnership, Hampstead Associates, Inc., a Texas corporation,
RAW Genpar, Inc., a Texas corporation, InMed, Inc. (d/b/a InCap, Inc.), Donald
J. McNamara, Robert A. Whitman and Daniel A. Decker (collectively referred to
herein as the "Filing Parties").
WHEREAS, Rule 13d-1(f)(1)(iii) under the Securities Exchange Act of
1934, as amended (the "Act"), requires that, when a Schedule 13D is filed on
behalf of more than one person, an agreement be executed and filed as an exhibit
to the Schedule 13D reflecting that the Schedule 13D is being filed on behalf of
all such persons:
NOW, THEREFORE, in consideration of the premises and the mutual
promises stated herein, the Filing Parties hereby agree as follows:
(i) Each Filing Party agrees that a single Schedule 13D (and any
amendments thereto) shall be filed jointly on behalf of all the Filing Parties
with respect to the shares of common stock, $.01 par value per share, of Wyndham
Hotel Corporation, a Delaware corporation.
(ii) Each Filing Party acknowledges and agrees that, pursuant to Rule
13d-1(f)(1) under the Act, each Filing Party individually is (i) eligible to use
the Schedule 13D and (ii) responsible for the timely filing of such Schedule 13D
and any amendments thereto and for the completeness and accuracy of the
information concerning such Filing Party contained in such Schedule 13D. None of
the Filing Parties, however, shall be responsible for the completeness or
accuracy of information concerning any other Filing Party contained in such
Schedule 13d, or any amendments thereto, unless such Filing Party knows or has
reason to believe that such information is incomplete or inaccurate.
(iii) This agreement shall not be assignable by any Filing Party. Any
assignment in violation of the foregoing shall be null and void.
(iv) This agreement shall terminate upon the written notice of
termination given by any Filing Party to the other Filing Parties.
(v) This agreement may be executed in several counterparts, each of
which shall be deemed to be an original copy hereof.
<PAGE> 2
IN WITNESS WHEREOF, the undersigned hereby executed this Agreement
Among Filing Parties as of the date or dates set forth below.
DATED: June 3, 1996 WYNOPT INVESTMENT PARTNERSHIP
LEVEL II, L.P.
By: Hampstead Genpar, L.P.
Its General Partner
By: HH Genpar Partners
Its General Partner
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ Daniel A. Decker
----------------------------
Daniel A. Decker
Executive Vice President
DATED: June 3, 1996 HAMPSTEAD GENPAR, L.P.
By: HH Genpar Partners
Its General Partner
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ Daniel A. Decker
------------------------------
Daniel A. Decker
Executive Vice President
DATED: June 3, 1996 HH GENPAR PARTNERS
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ Daniel A. Decker
------------------------------
Daniel A. Decker
Executive Vice President
Page 19 of 22 Pages
<PAGE> 3
DATED: June 3, 1996 HAMPSTEAD ASSOCIATES, INC.
By: /s/ Daniel A. Decker
------------------------------
Daniel A. Decker
Executive Vice President
DATED: June 3, 1996 RAW GENPAR, INC.
By: /s/ Robert A. Whitman
------------------------------
Robert A. Whitman
President
DATED: June 3, 1996 INMED, INC.
By: /s/ Daniel A. Decker
------------------------------
Daniel A. Decker
President
DATED: June 3, 1996 /s/ Donald J. McNamara
---------------------------------
Donald J. McNamara
DATED: June 3, 1996 /s/ Robert A. Whitman
---------------------------------
Robert A. Whitman
DATED: June 3, 1996 /s/ Daniel A. Decker
---------------------------------
Daniel A. Decker
Page 20 of 22 Pages
